John S. Montalbano, Director at AbCellera Biologics Inc. (ABCL), bought 20,000 shares at $4.77 ($95K) on 2026-05-14, disclosed to the SEC on 2026-05-18.
Open-market purchase of $95k ABCL by Director. Below the thresholds we flag for high-conviction alerts (no C-suite role, rare reversal, cluster, or A-grade history). Context: insider career grade C.
Nothing distinguishes this filing.
| Filing → |
| ABCL | BUY | 2025-03-10 | $115K | — | Filing → |
| ABCL | BUY | 2025-03-07 | $140K | — | Filing → |
| ABCL | BUY | 2023-11-08 | $137K | — | Filing → |